Stuart Allen Jones

Stuart Allen Jones

Auto-generated profile, based on publicly available information

Stuart Allen Jones

Centre for Pharmaceutical Medicine Research, Institute of Pharmaceutical Science, Franklin-Wilkins Building, King's College London, Faculty of Life Sciences & Medicine , London

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2007 in Pharmaceutical Research
Verified
Journal Article
Closed access
PDF file
RKR. H. Khengar
R. H. Khengar
SJS. A. Jones
S. A. Jones
RTR. B. Turner
R. B. Turner
BFB. Forbes
B. Forbes
MBM. B. Brown
M. B. Brown

1 January 2019 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Open access
RHRobert A. Harper
Robert A. Harper
GCGH Carpenter
GH Carpenter
GPGordon B. Proctor
Gordon B. Proctor
RHRichard D. Harvey
Richard D. Harvey
RGRobert J. Gambogi
Robert J. Gambogi
SJStuart A. Jones
Stuart A. Jones
The extracellular polymer substances (EPS) generated by biofilms confers resistance to antimicrobial agents through electrostatic and steric interactions that hinder molecular diffusion. This resistance mechanism is particularly evident for antibacterial nanomaterials, which inherently diffuse more slowly compared to small organic antibacterial agents. The aim of this study was to determine if a biofilm's resistance to antibacterial nanomaterial diffusion could be diminished using electrolytes to screen the EPS's electrostatic interactions. Anionic (+) alpha-tocopherol phosphate (α-TP) liposomes were used as the antimicrobial nanomaterials in the study. They self-assembled into 700 nm sized structures with a zeta potential of -20 mV that were capable of killing oral bacteria (S. oralis growth inhibition time of 3.34 ± 0.52 h). In a phosphate (-ve) buffer the -ve α-TP liposomes did not penetrate multispecies oral biofilms, but in a Tris (hydroxymethyl)aminomethane (+ve) buffer they did (depth - 12.4 ± 3.6 μm). The Tris did not modify the surface charge of the α-TP nanomaterials, rather it facilitated the α-TP-biofilm interactions through electrolyte screening (Langmuir modelled surface pressure increase of 2.7 ± 1.8 mN/ m). This data indicated that EPS resistance was mediated through charge repulsion and that this effect could be diminished through the co-administration of cationic electrolytes.

22 November 2014 in Pharmaceutical Research
Verified
Journal Article
Open access
PDF file
ABA. Baraldi
A. Baraldi
SJS. A. Jones
S. A. Jones
SGS. Guesné
S. Guesné
MTM. J. Traynor
M. J. Traynor
WMW. J. McAuley
W. J. McAuley
SMS. Murdan
S. Murdan
Purpose Through the characterisation of the human onchomycotic nail plate this study aimed to inform the design of new topical ungual formulations. Methods The mechanical properties of the human nail were characterised using a Lloyd tensile strength tester. The nail’s density was determined via pycnometry and the nail’s ultrastructure by electron microscopy. Raman spectroscopy analysed the keratin disulphide bonds within the nail and its permeability properties were assessed by quantifying water and rhodamine uptake. Results Chronic in vivo nail plate infection increased human nailplate thickness (healthy 0.49 ± 0.15 mm; diseased 1.20 ± 0.67 mm), but reduced its tensile strength (healthy 63.7 ± 13.4 MPa; diseased 41.7 ± 5.0 MPa) and density (healthy 1.34 ± 0.01 g/cm3; diseased 1.29 ± 0.00 g/cm3). Onchomycosis caused cell-cell separation, without disrupting the nail disulfide bonds or desmosomes. The diseased and healthy nails showed equivalent water uptake profiles, but the rhodamine penetration was 4-fold higher in the diseased nails using a PBS vehicle and 3 -fold higher in an ethanol/PBS vehicle. Conclusions Onchomycotic nails presented a thicker but more porous barrier, and its eroded intracellular matrix rendered the tissue more permeable to topically applied chemicals when an aqueous vehicle was used.

1 May 2006 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
PDF file
SJStuart A. Jones
Stuart A. Jones
GMGary P. Martin
Gary P. Martin
MBMarc B. Brown
Marc B. Brown

1 March 2008 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
PDF file
Francesca ButtiniFrancesca Buttini
Francesca Buttini
PCP. Colombo
P. Colombo
MWM.P.E. Wenger
M.P.E. Wenger
PMP. Mesquida
P. Mesquida
CMC. Marriott
C. Marriott
SJStuart A. Jones
Stuart A. Jones

1 August 2013 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
MRMonica L. Reid
Monica L. Reid
FBFaiza Benaouda
Faiza Benaouda
RKRajeshree Khengar
Rajeshree Khengar
SJStuart A. Jones
Stuart A. Jones
MBMarc B. Brown
Marc B. Brown